COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol Ruchika Sharma15 Dec 2023 4:30 PM ISTBangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO)...
Dapagliflozin NOT off Patent, says AstraZeneca Medical Dialogues Bureau23 Nov 2020 3:14 PM ISTNew Delhi: The arrival of SGLT-2 inhibitors or Glifozins, has brought a major change in the management of Diabetes in the past decade. Numerous pharma...
